Aduro Full Logo_Two Color.png
Aduro Announces Stock Option Grants
20 juin 2022 19h32 HE | Aduro Clean Technologies Inc.
SARNIA, Ontario, June 20, 2022 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
Nasdaq.jpg.prdesk.globenewswire.jpg
Aduro Biotech, Inc. (Nasdaq: ADRO) to Ring The Nasdaq Stock Market Opening Bell
27 mars 2017 10h00 HE | NASDAQ, Inc.
ADVISORY, March 27, 2017 (GLOBE NEWSWIRE) -- What:Aduro Biotech, Inc. (Nasdaq:ADRO), an immunotherapy company focused on the discovery, development and commercialization of therapies that...
Chinook Logo.png
Aduro Biotech Appoints Liana Wu as Vice President of Commercial
02 juin 2015 08h00 HE | Chinook Therapeutics, Inc.
BERKELEY, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that Liana Wu has joined the company as vice president, commercial. Ms. Wu, a commercial leader...
Chinook Logo.png
Aduro Biotech Announces ASCO Presentation of Encouraging Data From Ongoing Phase 1b Clinical Trial of Its Immunotherapy for the Treatment of Mesothelioma
01 juin 2015 09h00 HE | Chinook Therapeutics, Inc.
BERKELEY, Calif., June 1, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the presentation of interim safety and efficacy data from an ongoing Phase 1b clinical trial of its...
Chinook Logo.png
Aduro Biotech Announces First Quarter 2015 Financial Results
28 mai 2015 16h00 HE | Chinook Therapeutics, Inc.
Established major $750M collaboration with Novartis for STING in oncology Strengthened cash position with $200M upfront payment from Novartis and $149.3M in net proceeds from IPO and...